{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T10:47:21Z","timestamp":1780397241440,"version":"3.54.1"},"reference-count":53,"publisher":"American Association for Cancer Research (AACR)","issue":"12","license":[{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"BPGbio Inc."}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>BPM31510IV, a highly bioavailable intravenously administered coenzyme Q10 (CoQ10) formulation, was evaluated in a phase Ia\/Ib study as monotherapy and in combination with chemotherapy in patients with advanced solid tumors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods:<\/jats:title>\n                    <jats:p>Using a 3 + 3 design, patients received twice-weekly intravenous infusions of BPM31510IV monotherapy (arm 1) or combined with gemcitabine, 5-fluorouracil\/leucovorin, or docetaxel (arm 2); crossover between arms was permitted. Tumor response was assessed by RECIST1.1. Pharmacokinetic and multiomics pharmacodynamic (PD) analyses were performed on plasma and core biopsy samples.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A total of 97 patients were enrolled, 33 in arm 1 and 71 in arm 2 (seven patients crossed from arm 1 to arm 2). The MTD was 171 mg\/kg for BPM31510IV monotherapy or with 5-fluorouracil\/leucovorin and 110 mg\/kg with gemcitabine or docetaxel. Four dose-limiting toxicities occurred (two in monotherapy; two in combination with chemotherapy). Most adverse events were coagulation-related, occurring in 96% of patients (grade \u22653 in 4%). Pharmacokinetics showed dose-proportional increases in CoQ10 levels to supraphysiologic concentrations (&amp;gt;200\u00d7). In arm 1, there was one (3%) partial response (PR), with stable disease (SD) reported in eight (24%) patients. In arm 2, there was one (1%) PR, with SD reported in 25 (35%) patients. Fluorodeoxyglucose-PET imaging and PD data suggest a change in tumor metabolism from glycolysis to oxidative phosphorylation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>BPM31510IV as monotherapy and in combination with chemotherapy was safe, with preliminary evidence of antitumor activity. High plasma CoQ10 levels were achieved, inducing PD responses consistent with mitochondrial metabolic changes. These findings support continued clinical development of BPM31510IV.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>BPM31510IV is a lipid nanodispersion of oxidized CoQ10 that alters the Warburg effect and displays anticancer activity. BPM31510IV seems to synergize with chemotherapy to induce cancer cell apoptosis, likely through mitochondrial priming. An initial phase I monotherapy study demonstrated that BPM31510IV is well tolerated in patients with advanced solid tumors. Based on these observations, the safety and preliminary antitumor activity of BPM31510IV were further explored in a phase Ia\/Ib study in combination with chemotherapy. Results indicated that BPM31510IV monotherapy and BPM31510IV combined with chemotherapy are well tolerated, demonstrating preliminary evidence of antitumor activity and inducing physiologic and molecular changes consistent with altered mitochondrial metabolism. The most common adverse events were changes in coagulation parameters. Overall, this study provides valuable MTD and surrogate efficacy data that support the continued clinical development of BPM31510IV.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-25-0507","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T11:16:46Z","timestamp":1763464606000},"page":"2207-2223","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Phase Ia\/b Multicenter Study of BPM31510IV Targeting Mitochondrial Metabolism\/Warburg Effect as Monotherapy and Combination Chemotherapy in Solid Tumor Patients"],"prefix":"10.1158","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6064-6837","authenticated-orcid":false,"given":"Vivek","family":"Subbiah","sequence":"first","affiliation":[{"name":"1MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0982-923X","authenticated-orcid":false,"given":"Peter P.","family":"Yu","sequence":"additional","affiliation":[{"name":"2Palo Alto Medical Foundation, Sunnyvale, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9403-9421","authenticated-orcid":false,"given":"Rangaprasad","family":"Sarangarajan","sequence":"additional","affiliation":[{"name":"3BPGbio Inc., Waltham, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5678-0072","authenticated-orcid":false,"given":"Michael A.","family":"Kiebish","sequence":"additional","affiliation":[{"name":"3BPGbio Inc., Waltham, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8009-5174","authenticated-orcid":false,"given":"Leonardo O.","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"3BPGbio Inc., Waltham, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7397-9277","authenticated-orcid":false,"given":"Gregory M.","family":"Miller","sequence":"additional","affiliation":[{"name":"3BPGbio Inc., Waltham, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8361-7708","authenticated-orcid":false,"given":"Viatcheslav R.","family":"Akmaev","sequence":"additional","affiliation":[{"name":"3BPGbio Inc., Waltham, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2654-6482","authenticated-orcid":false,"given":"Shen","family":"Luan","sequence":"additional","affiliation":[{"name":"3BPGbio Inc., Waltham, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7165-471X","authenticated-orcid":false,"given":"John P.","family":"McCook","sequence":"additional","affiliation":[{"name":"4Discovery Partners, LLC., Frisco, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7770-7651","authenticated-orcid":false,"given":"Nikunj","family":"Tanna","sequence":"additional","affiliation":[{"name":"3BPGbio Inc., Waltham, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9879-8439","authenticated-orcid":false,"given":"Tracey","family":"Reilly","sequence":"additional","affiliation":[{"name":"3BPGbio Inc., Waltham, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5967-8727","authenticated-orcid":false,"given":"Emily","family":"Chen","sequence":"additional","affiliation":[{"name":"3BPGbio Inc., Waltham, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6830-3788","authenticated-orcid":false,"given":"Valerie","family":"Bussberg","sequence":"additional","affiliation":[{"name":"3BPGbio Inc., Waltham, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7161-1568","authenticated-orcid":false,"given":"Shobha","family":"Ravipaty","sequence":"additional","affiliation":[{"name":"3BPGbio Inc., Waltham, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1453-1507","authenticated-orcid":false,"given":"Vivek K.","family":"Vishnudas","sequence":"additional","affiliation":[{"name":"3BPGbio Inc., Waltham, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2165-3814","authenticated-orcid":false,"given":"Stephane","family":"Gesta","sequence":"additional","affiliation":[{"name":"3BPGbio Inc., Waltham, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0014-8187","authenticated-orcid":false,"given":"David","family":"Lucius","sequence":"additional","affiliation":[{"name":"3BPGbio Inc., Waltham, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3101-1250","authenticated-orcid":false,"given":"Can","family":"Bruce","sequence":"additional","affiliation":[{"name":"3BPGbio Inc., Waltham, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4980-4704","authenticated-orcid":false,"given":"Suwagmani","family":"Hazarika","sequence":"additional","affiliation":[{"name":"3BPGbio Inc., Waltham, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8656-6295","authenticated-orcid":false,"given":"Arianne","family":"Lyng","sequence":"additional","affiliation":[{"name":"3BPGbio Inc., Waltham, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3361-7627","authenticated-orcid":false,"given":"Allison","family":"Klotz","sequence":"additional","affiliation":[{"name":"3BPGbio Inc., Waltham, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0445-884X","authenticated-orcid":false,"given":"Vladimir","family":"Tolstikov","sequence":"additional","affiliation":[{"name":"3BPGbio Inc., Waltham, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3786-650X","authenticated-orcid":false,"given":"Janice","family":"Stevens","sequence":"additional","affiliation":[{"name":"3BPGbio Inc., Waltham, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2651-3625","authenticated-orcid":false,"given":"Victoria S.","family":"Chua","sequence":"additional","affiliation":[{"name":"5Sarcoma Oncology Center, Santa Monica, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3643-9547","authenticated-orcid":false,"given":"Elder","family":"Granger","sequence":"additional","affiliation":[{"name":"3BPGbio Inc., Waltham, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6594-8310","authenticated-orcid":false,"given":"Poornima K.","family":"Tekumalla","sequence":"additional","affiliation":[{"name":"3BPGbio Inc., Waltham, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4464-8610","authenticated-orcid":false,"given":"Ely","family":"Benaim","sequence":"additional","affiliation":[{"name":"3BPGbio Inc., Waltham, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3720-7553","authenticated-orcid":false,"given":"Vijay","family":"Modur","sequence":"additional","affiliation":[{"name":"3BPGbio Inc., Waltham, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5037-4620","authenticated-orcid":false,"given":"Marc S.","family":"Rudoltz","sequence":"additional","affiliation":[{"name":"6MSR Healthcare Consultants, LLC., Pittsfield, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3270-0324","authenticated-orcid":false,"given":"Paul Y.","family":"Song","sequence":"additional","affiliation":[{"name":"3BPGbio Inc., Waltham, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2777-8587","authenticated-orcid":false,"given":"Scott T.","family":"Tagawa","sequence":"additional","affiliation":[{"name":"7Weill Cornell Medical College, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2079-9177","authenticated-orcid":false,"given":"Andrew","family":"Hendifer","sequence":"additional","affiliation":[{"name":"8Cedars-Sinai Medical Center, Samuel Oschin Cancer Center, Los Angeles, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9522-6744","authenticated-orcid":false,"given":"Sant P.","family":"Chawla","sequence":"additional","affiliation":[{"name":"9Cancer Center of Southern California, Santa Monica, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6913-9655","authenticated-orcid":false,"given":"Manish A.","family":"Shah","sequence":"additional","affiliation":[{"name":"7Weill Cornell Medical College, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8721-1609","authenticated-orcid":false,"given":"David S.","family":"Hong","sequence":"additional","affiliation":[{"name":"1MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6812-5540","authenticated-orcid":false,"given":"Ralph","family":"Zinner","sequence":"additional","affiliation":[{"name":"1MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6769-1748","authenticated-orcid":false,"given":"Niven R.","family":"Narain","sequence":"additional","affiliation":[{"name":"3BPGbio Inc., Waltham, Massachusetts."},{"name":"10Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida."},{"name":"11Department of Biochemistry & Molecular Biology, University of Miami Miller School of Medicine, Miami, Florida."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9237-2666","authenticated-orcid":false,"given":"Madappa N.","family":"Kundranda","sequence":"additional","affiliation":[{"name":"12Banner MD Anderson Cancer Center at Banner Gateway Medical Center, Gilbert, Arizona."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"key":"2025122320505726700_bib1","first-page":"339","article-title":"Oxidative metabolism in cancer growth","volume":"9","author":"Ristow","year":"2006","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"2025122320505726700_bib2","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrc3038","article-title":"Otto Warburg\u2019s contributions to current concepts of cancer metabolism","volume":"11","author":"Koppenol","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"2025122320505726700_bib3","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","article-title":"Metabolic reprogramming: a cancer Hallmark even Warburg did not anticipate","volume":"21","author":"Ward","year":"2012","journal-title":"Cancer Cell"},{"key":"2025122320505726700_bib4","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"2025122320505726700_bib5","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1021\/pr2009274","article-title":"Proteomic analysis reveals Warburg effect and anomalous metabolism of glutamine in pancreatic cancer cells","volume":"11","author":"Zhou","year":"2012","journal-title":"J Proteome Res"},{"key":"2025122320505726700_bib6","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.bbabio.2016.03.036","article-title":"Coenzyme Q biosynthesis in health and disease","volume":"1857","author":"Acosta","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"2025122320505726700_bib7","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3389\/fphys.2018.00044","article-title":"Coenzyme Q10 supplementation in aging and disease","volume":"9","author":"Hern\u00e1ndez-Camacho","year":"2018","journal-title":"Front Physiol"},{"key":"2025122320505726700_bib8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000360101","article-title":"Coenzyme Q10 therapy","volume":"5","author":"Garrido-Maraver","year":"2014","journal-title":"Mol Syndromol"},{"key":"2025122320505726700_bib9","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.2217\/fon-2016-0547","article-title":"Coenzyme Q10 in breast cancer care","volume":"13","author":"Tafazoli","year":"2017","journal-title":"Future Oncol"},{"key":"2025122320505726700_bib10","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.radonc.2018.04.033","article-title":"Regulation of the oxidative balance with coenzyme Q10 sensitizes human glioblastoma cells to radiation and temozolomide","volume":"128","author":"Fronti\u00f1\u00e1n-Rubio","year":"2018","journal-title":"Radiother Oncol"},{"issue":"Suppl","key":"2025122320505726700_bib11","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/j.mito.2007.03.003","article-title":"Plasma coenzyme Q10 response to oral ingestion of coenzyme Q10 formulations","volume":"7","author":"Bhagavan","year":"2007","journal-title":"Mitochondrion"},{"key":"2025122320505726700_bib12","first-page":"65","article-title":"Coenzyme Q10 induces apoptosis in human prostate and osteosarcoma cells","volume":"65","author":"Persaud","year":"2005","journal-title":"Cancer Res"},{"issue":"Suppl 9","key":"2025122320505726700_bib13","first-page":"1819","article-title":"Induction of p53 by Coenzyme Q10 via modulation of mdm2 and p14","volume":"68","author":"Persaud","year":"2008","journal-title":"Cancer Res"},{"key":"2025122320505726700_bib14","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1158\/1538-7445.AM2014-3358","article-title":"Abstract 3358: significant increase in survival of triple negative breast cancer animal model in response to BPM31510 alone or in combination with standard of care: BPM31510 mediated dynamic metabolic (Warburg) shift in breast cancer as potential mechanism","volume":"74","author":"Narain","year":"2014","journal-title":"Cancer Res"},{"key":"2025122320505726700_bib15","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1158\/1538-7445.AM2017-1497","article-title":"Abstract 1497: BPM31510 modulates mitochondrial complex activity to influence oxidative stress in effectuating cell death in multiple cancers","volume":"77","author":"Dadali","year":"2017","journal-title":"Cancer Res"},{"key":"2025122320505726700_bib16","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1158\/1538-7445.AM2018-3530","article-title":"Abstract 3530: Coenzyme Q10 (BPM31510IV in clinical trials) increases mitochondrial Qpool and modulates electron transport chain function to elicit cell death in pancreatic cancer cells","volume":"78","author":"Awate","year":"2018","journal-title":"Cancer Res"},{"key":"2025122320505726700_bib17","doi-asserted-by":"crossref","first-page":"13899","DOI":"10.1038\/s41598-020-70969-0","article-title":"High levels of ubidecarenone (oxidized CoQ10) delivered using a drug-lipid conjugate nanodispersion (BPM31510) differentially affect redox status and growth in malignant glioma versus non-tumor cells","volume":"10","author":"Sun","year":"2020","journal-title":"Sci Rep"},{"key":"2025122320505726700_bib18","doi-asserted-by":"crossref","first-page":"5749","DOI":"10.1038\/s41598-021-84852-z","article-title":"Elevated levels of mitochondrial CoQ10 induce ROS-mediated apoptosis in pancreatic cancer","volume":"11","author":"Dadali","year":"2021","journal-title":"Sci Rep"},{"key":"2025122320505726700_bib19","doi-asserted-by":"crossref","first-page":"e14593","DOI":"10.1200\/jco.2012.30.15_suppl.e14593","article-title":"Effect of BPM 31510 on survival outcomes when used in combination with gemcitabine in a preclinical model of pancreatic cancer","volume":"30","author":"Jimenez","year":"2012","journal-title":"J Clin Oncol"},{"key":"2025122320505726700_bib20","doi-asserted-by":"crossref","first-page":"5576","DOI":"10.1158\/1538-7445.AM2017-5576","article-title":"Abstract 5576: BPM 31510, a clinical stage candidate demonstrates potent antitumor effect in an immunecompetent syngeneic pancreatic cancer model","volume":"77","author":"Kazerounian","year":"2017","journal-title":"Cancer Res"},{"key":"2025122320505726700_bib21","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1158\/1538-7445.AM2018-873","article-title":"Abstract 873: BPM 31510, a clinical stage metabolic modulator, demonstrates therapeutic efficacy in glioblastoma models of temozolomide chemosensitive and resistance by targeting mitochondrial function","volume":"78","author":"Dadali","year":"2018","journal-title":"Cancer Res"},{"key":"2025122320505726700_bib22","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1158\/1538-7445.AM2019-3608","article-title":"Abstract 3608: BPM31510 exploits differential redox vulnerabilities between normal and glioblastoma cells to mediate its anticancer effect","volume":"79","author":"Sun","year":"2019","journal-title":"Cancer Res"},{"key":"2025122320505726700_bib23","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1200\/jco.2012.30.15_suppl.3015","article-title":"Phase I study of BPM 31510 in advanced solid tumors: updated analysis of a novel treatment with promising activity","volume":"30","author":"Hendifar","year":"2012","journal-title":"J Clin Oncol"},{"key":"2025122320505726700_bib24","doi-asserted-by":"crossref","first-page":"ix166","DOI":"10.1016\/S0923-7534(20)33043-X","article-title":"Phase 1 study of Bpm 31510 (UBIDECARANONE) in advanced solid tumors: updated analysis of a novel treatment with promising activity","volume":"23","author":"Chawla","year":"2012","journal-title":"Ann Oncol"},{"key":"2025122320505726700_bib25","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1158\/1538-7445.AM2013-1736","article-title":"Abstract 1736: mitochondrial priming of apoptotic machinery in pancreatic cancer by BPM 31510 to enhance efficacy of chemotherapy","volume":"73","author":"Narain","year":"2013","journal-title":"Cancer Res"},{"key":"2025122320505726700_bib26","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1182\/blood.V122.21.1457.1457","article-title":"Parenteral CoQ10 formulation (BPM31510) significantly improves survival in animal model of leukemia including the resolution of paraplegia due to brain metastasis","volume":"122","author":"Narain","year":"2013","journal-title":"Blood"},{"key":"2025122320505726700_bib27","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1158\/1538-7445.AM2016-212","article-title":"Abstract 212: BPM 31510 synergizes gemcitabine efficacy in pancreatic adenocarcinoma via mechanism independent of its antiWarburg influence on metabolism","volume":"76","author":"Dadali","year":"2016","journal-title":"Cancer Res"},{"key":"2025122320505726700_bib28","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/jnci\/djp079","article-title":"Dose escalation methods in phase I cancer clinical trials","volume":"101","author":"Le Tourneau","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"2025122320505726700_bib29","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"key":"2025122320505726700_bib30","volume-title":"Common Terminology Criteria for Adverse Events (CTCAE)|Protocol Development|CTEP","author":"National Institutes of Health","year":"2023"},{"key":"2025122320505726700_bib31","doi-asserted-by":"crossref","first-page":"e13442","DOI":"10.7554\/eLife.13442","article-title":"Microbiota-driven transcriptional changes in prefrontal cortex override genetic differences in social behavior","volume":"5","author":"Gacias","year":"2016","journal-title":"eLife"},{"key":"2025122320505726700_bib32","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/s41598-022-05152-8","article-title":"Impact of hemolysis on multi-OMIC pancreatic biomarker discovery to derisk biomarker development in precision medicine studies","volume":"12","author":"Searfoss","year":"2022","journal-title":"Sci Rep"},{"key":"2025122320505726700_bib33","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12014-020-09300-y","article-title":"Comparative analysis of differentially abundant proteins quantified by LC\u2013MS\/MS between flash frozen and laser microdissected OCT-embedded breast tumor samples","volume":"17","author":"Sturtz","year":"2020","journal-title":"Clin Proteom"},{"key":"2025122320505726700_bib34","doi-asserted-by":"crossref","first-page":"e114019","DOI":"10.1371\/journal.pone.0114019","article-title":"Metabolomics analysis of metabolic effects of Nicotinamide Phosphoribosyltransferase (NAMPT) inhibition on human cancer cells","volume":"9","author":"Tolstikov","year":"2014;","journal-title":"PLoS One"},{"key":"2025122320505726700_bib35","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3390\/metabo7030035","article-title":"Integrated metabolomics assessment of human dried blood spots and urine strips","volume":"7","author":"Drolet","year":"2017","journal-title":"Metabolites"},{"key":"2025122320505726700_bib36","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.2337\/db18-0462","article-title":"Regulation of human adipose tissue activation, gallbladder size, and bile acid metabolism by a \u03b23-adrenergic receptor agonist","volume":"67","author":"Baskin","year":"2018","journal-title":"Diabetes"},{"key":"2025122320505726700_bib37","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12967-019-02185-y","article-title":"Multi-omic serum biomarkers for prognosis of disease progression in prostate cancer","volume":"18","author":"Kiebish","year":"2020","journal-title":"J Transl Med"},{"key":"2025122320505726700_bib38","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/978-1-61737-985-7_13","article-title":"LC-MS-based metabolomics","volume":"708","author":"Bajad","year":"2011","journal-title":"Methods Mol Biol"},{"key":"2025122320505726700_bib39","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/nprot.2011.335","article-title":"Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry","volume":"6","author":"The Human Serum Metabolome (HUSERMET) Consortium","year":"2011","journal-title":"Nat Protoc"},{"key":"2025122320505726700_bib40","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/nprot.2012.024","article-title":"A positive\/negative ion\u2013switching, targeted mass spectrometry\u2013based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue","volume":"7","author":"Yuan","year":"2012","journal-title":"Nat Protoc"},{"key":"2025122320505726700_bib41","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nprot.2012.135","article-title":"Global metabolic profiling of animal and human tissues via UPLC-MS","volume":"8","author":"Want","year":"2013","journal-title":"Nat Protoc"},{"key":"2025122320505726700_bib42","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3390\/metabo6030025","article-title":"Monoacylglycerol analysis using MS\/MSALL quadruple time of flight mass spectrometry","volume":"6","author":"Gao","year":"2016","journal-title":"Metabolites"},{"key":"2025122320505726700_bib43","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nm.4297","article-title":"The cold-induced lipokine 12,13-diHOME promotes fatty acid transport into brown adipose tissue","volume":"23","author":"Lynes","year":"2017","journal-title":"Nat Med"},{"key":"2025122320505726700_bib44","first-page":"11","article-title":"Extraction of eicosanoids from biological fluids, cells, and tissues","volume":"120","author":"Powell","year":"1999","journal-title":"Methods Mol Biol"},{"key":"2025122320505726700_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v082.i13","article-title":"lmerTest package: tests in linear mixed effects models","volume":"82","author":"Kuznetsova","year":"2017","journal-title":"J Stat Softw"},{"key":"2025122320505726700_bib46","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1214\/aos\/1074290335","article-title":"The positive false discovery rate: a Bayesian interpretation and the q-value","volume":"31","author":"Storey","year":"2003","journal-title":"Ann Stat"},{"key":"2025122320505726700_bib47","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2307\/2342435","article-title":"The logic of inductive inference","volume":"98","author":"Fisher","year":"1935","journal-title":"J R Stat Soc"},{"key":"2025122320505726700_bib48","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1467-842X.1962.tb00285.x","article-title":"Confidence LIMITS for a cross-product ratio","volume":"4","author":"Fisher","year":"1962","journal-title":"Aust J Stat"},{"key":"2025122320505726700_bib49","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Ser B"},{"key":"2025122320505726700_bib50","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.tcb.2023.03.013","article-title":"The Warburg effect: a signature of mitochondrial overload","volume":"33","author":"Wang","year":"2023","journal-title":"Trends Cell Biol"},{"key":"2025122320505726700_bib51","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1080\/10428190601078118","article-title":"PET and PET\/CT for response evaluation in lymphoma: current practice and developments","volume":"48","author":"Brepoels","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"2025122320505726700_bib52","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.chemphyslip.2011.06.008","article-title":"Plasmalogens the neglected regulatory and scavenging lipid species","volume":"164","author":"Wallner","year":"2011","journal-title":"Chem Phys Lipids"},{"key":"2025122320505726700_bib53","doi-asserted-by":"crossref","first-page":"S426","DOI":"10.1016\/j.annonc.2024.08.568","article-title":"499TiP A phase II study of BPM31510 (a lipid nanodispersion of oxidized CoQ10) with vitamin K in combination with standard of care (SOC) RT and TMZ in glioblastoma multiforme (GBM) patients without prior therapy","volume":"35","author":"Stockdale","year":"2024","journal-title":"Ann Oncol"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-25-0507\/3671655\/crc-25-0507.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/5\/12\/2207\/3718200\/crc-25-0507.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/5\/12\/2207\/3718200\/crc-25-0507.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T01:51:09Z","timestamp":1766541069000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/5\/12\/2207\/771175\/Phase-Ia-b-Multicenter-Study-of-BPM31510IV"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":53,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-25-0507","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.30944154","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30944100","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30944097","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30944112","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30944124","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30944130","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30944142","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30944118","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30944136","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30944148","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30944106","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30944094","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30944121","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30944133","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30944145","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30944157","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30944151","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30944163","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30944088","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30944109","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30944103","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30944115","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30944127","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30944139","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30944160","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30944091","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.c.8216454","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]}}}